This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have upgraded their ratings for several companies, including Planet Fitness, Cinemark Holdings, Sirius XM Holdings, Digimarc Corporation, and Solid Biosciences. These upgrades come with revised price targets, indicating a positive outlook for these stocks.
June 24, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evercore ISI Group upgraded Sirius XM Holdings from Underperform to In-Line, lowering the price target from $4.25 to $3.25. Shares closed at $2.93 on Friday.
While the rating was upgraded, the lowered price target suggests mixed signals. The short-term impact on the stock price is likely to be neutral.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Roth MKM upgraded Cinemark Holdings from Neutral to Buy, increasing the price target from $19 to $26. Shares closed at $19.48 on Friday.
The upgrade to Buy and the higher price target indicate a positive outlook for Cinemark Holdings, likely resulting in a short-term boost to the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Needham upgraded Digimarc Corporation from Hold to Buy with a new price target of $40. Shares closed at $26.24 on Friday.
The upgrade to Buy and the new price target indicate a strong positive outlook for Digimarc Corporation, likely leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TD Cowen upgraded Planet Fitness from Hold to Buy, raising the price target from $66 to $92. Shares closed at $72.73 on Friday.
The upgrade from Hold to Buy and the significant increase in the price target suggest strong confidence in Planet Fitness's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Leerink Partners upgraded Solid Biosciences from Market Perform to Outperform, maintaining a price target of $12. Shares closed at $6.46 on Friday.
The upgrade to Outperform and the maintained price target suggest a positive outlook for Solid Biosciences, likely resulting in a short-term boost to the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100